Lisaftoclax Plus Pirtobrutinib in Relapsed or Refractory Mantle Cell Lymphoma After BTK-Targeted Therapy
Clinical trial NCT07684950 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07684950
- Sponsor
- Henan Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2028-10-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.